Madrigal Pharmaceuticals, Inc.MDGLNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-190.02M
↓ 15% vs avg
Percentile
P21
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-164.72M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-190.02M | +58.4% |
| 2024 | $-457.03M | -40.3% |
| 2023 | $-325.71M | -44.7% |
| 2022 | $-225.07M | -22.2% |
| 2021 | $-184.13M | -16.6% |
| 2020 | $-157.90M | -277.8% |
| 2019 | $-41.80M | -63.7% |
| 2018 | $-25.53M | -13.8% |
| 2017 | $-22.44M | -27.4% |
| 2016 | $-17.61M | - |